Consequently, we aimed here to investigate comprehensively MGMT promoter methylation and MGMT immunohistochemistry in brain metastases derived from lung, breast and renal cell carcinomas as well as from malignant melanomas. This evidence concerns the gene MGMT and hereditary clear cell renal cell carcinoma.